Hoppa till huvudinnehållet

NorwayNorwayAQUA BIO TECHNOLOGY
(ABTEC)

· Euronext Expand Oslo
· Valuta i NOK
Euronext Expand Oslo
Senast
5,00
Idag %
−1,57%
Idag +/-
−0,08
Köp
4,24
Sälj
5,46
Högst
5,20
Lägst
4,70
Omsatt (Antal)
164 120
· Euronext Expand Oslo
· Valuta i NOK
Euronext Expand Oslo
· Euronext Expand Oslo · Valuta i NOK
· Valuta i NOK
Euronext Expand Oslo
Senast
5,00
Utveckling idag
−1,57%
−0,08
Köp
4,24
Sälj
5,46
Högst
5,20
Lägst
4,70
Omsatt (Antal)
164 120
Q4-rapport
SNART
Idag
0,00 NOK/aktie
Senaste utdelning

Orderdjup

Stängd
Antal
Köp
100
Sälj
Antal
1 000

Senaste avslut

TidPrisAntalKöpareSäljare
3 999--
1--
999--
1 200--
1 307--
Omsättning (NOK)
816 271

Vi vill bara påminna om att börsen ger och tar. Även om sparande i aktier historiskt gett god avkastning över tid finns inga garantier för framtida avkastning. Det finns risk att du inte får tillbaka de pengar du investerat.

Mäklarstatistik

Ingen data hittades

Företagshändelser

Nästa händelse
2023 Q4-rapport
26 apr.
Idag
Tidigare händelser
2023 Q2-rapport24 aug. 2023
2022 Årsstämma9 juni 2023
2022 Q4-rapport28 apr. 2023
2022 Q2-rapport24 aug. 2022
2021 Årsstämma9 juni 2022
Data hämtas från Millistream, Quartr

Relaterade värdepapper

Inga Nordnet Markets Certifikat finns med underliggande värdepapper. Se övriga Certifikat

Kunder har även besökt

Nyheter & Analyser

Nyheter och/eller generella investeringsrekommendationer alternativt utdrag därav på denna sida och relaterade länkar är framtagna och tillhandahålls av den leverantör som anges. Nordnet har inte medverkat till framtagandet, granskar inte och har inte gjort några ändringar i materialet. Läs mer om investeringsrekommendationer.
Q4-rapport
SNART
Idag

Nyheter & Analyser

Nyheter och/eller generella investeringsrekommendationer alternativt utdrag därav på denna sida och relaterade länkar är framtagna och tillhandahålls av den leverantör som anges. Nordnet har inte medverkat till framtagandet, granskar inte och har inte gjort några ändringar i materialet. Läs mer om investeringsrekommendationer.

Företagshändelser

Nästa händelse
2023 Q4-rapport
26 apr.
Idag
Tidigare händelser
2023 Q2-rapport24 aug. 2023
2022 Årsstämma9 juni 2023
2022 Q4-rapport28 apr. 2023
2022 Q2-rapport24 aug. 2022
2021 Årsstämma9 juni 2022
Data hämtas från Millistream, Quartr

Relaterade värdepapper

Inga Nordnet Markets Certifikat finns med underliggande värdepapper. Se övriga Certifikat

Shareville

Delta i diskussionerna på SharevilleFå inspiration från tusentals portföljer och diskutera med andra duktiga investerare.
Logga in
  • för 7 tim sedan
    för 7 tim sedan
    De guider en kvart mrd på årsbasis og da blir det mer. Jesper Brant og Håvard Lindstrøm bør genierklæres. 15 kr pr aksje er antagelig svært billig. Jeg venter på neste oppkjøp👍😊🇳🇴
    för 7 tim sedan
    för 7 tim sedan
    Snart 250M i omsetning, sammenligner vi med f.eks Navamedic som i fjor hadde litt over 500M i omsetning og har nå en kurs på 34 kr. Så da er 16 kr et fint tall.
  • för 8 tim sedan
    för 8 tim sedan
    Da fikk vi Q1 allerede: av første kvartal 2024, oppnådde 35 millioner kroner i brutto omsetning på konsolidert basis med positiv EBITDA. https://kommunikasjon.ntb.no/ir-files/17847556/3067/4387/Download%20announcement%20as%20PDF.pdf
    för 7 tim sedan
    för 7 tim sedan
    Hold fast… 🍾
  • för 13 tim sedan
    för 13 tim sedan
    Er dette siden deres? https://www.3din.no/
  • för 13 tim sedan
    för 13 tim sedan
    Ha.ha. Dette var grisebra. Kjøpe omsetning til lav pris, hvor target har bunnlinje og god historikk. Dette er et distribusjonscase. Tenkt det hele tiden. Kursmål 15-20 på dagens setup. Jeg venter egentlig på neste oppkjøp…👏
    för 11 tim sedan
    för 11 tim sedan
    Mistet kalkulatoren? Er selskapet plutselig verdt et par milliarder?
  • för 14 tim sedan · Ändrad
    för 14 tim sedan · Ändrad
    Aqua Bio Technology (“ABT” or the “Company” and together with its wholly owned subsidiaries, the “ABT Group”) has today, on 25 April 2024, entered into an agreement (the “Agreement”) with CoC Invest AS (“CoC Invest”) regarding the Company’s acquisition of all of the outstanding shares in the 3D Innovation Nordic AS (“3D”). Pursuant to the Agreement, the Company shall further acquire all of the outstanding shares in the companies Printprofil AS and Check Please AS (jointly with 3D, the “Target Group”) from CoC Invest in connection with the acquisition of 3D (jointly, the “Acquisitions”). The Target Group represents a major wholesale group in the Nordics. In 2023, the Target Group had an unaudited turnover of NOK 87.6 million, of which 3D had a turnover of NOK 73 million. The Target Group companies are profitable and EBIDTA for the Target Group in 2023 ended jointly at NOK 5 million. The completion of the Acquisitions is subject to satisfactory due diligence and approval from ABT’s board of directors. Under the Agreement, the purchase price for the Acquisitions shall be settled in a combination of shares and cash, subject to certain conditions. NOK 5 million shares in ABT will be issued at a price of NOK 6 per share, with a 3-year lock up. The cash will be total NOK 15 million, divided into two installments, depending on the Target Group’s financial results. The first NOK 5 million is triggered by an EBT of NOK 6 million in the Target Group, the next NOK 10 million when the Target Group achieves an EBT of NOK 10 million. 3D is a significant wholesale company with a market-leading sales department. The company, which has its head office and sales department in Hønefoss, has extensive distribution to all the major retail chains in Norway and pharmacies in Norway and Sweden, as well as selected customers in Denmark. The company has had considerable success in just a few years and is at the top of the Gazelle award (Gaselle-bedrift) for 2023. In particular, the acquisition of 3D gives ABT access to completely new distribution channels that we do not currently have access to in both Norway and Sweden. In interaction with ABT’s historical operations and the operations in our existing subsidiaries, this acquisition will provide significant synergies on several levels, says Håvard Lindstrøm, CEO of ABT. Briefly about the companies Check Please AS mainly sells cash register rolls and rolls for card terminals in retail chains. The company’s founders have imported and sold cash register rolls/rolls for bank terminals from 2002, since 2014 as Check Please. The company has industry-leading expertise in this area. The company had an unaudited turnover of NOK 7.6 million in 2023. Printprofil AS is a company specialized in profiling and gift items, which is connected to New Wave and its thousands of customers. The company had an unaudited turnover of NOK 7 million in 2023. Scaling In addition to significant synergies between ABT’s historical and current operations, the acquisition of 3D also ensures that ABT gets the opportunity to scale its operations out of Norway to a greater extent. As of today, ABT’s presence outside Norway is limited in Sweden, through the ownership of Ultrabody AB. We are far from done with Norway, but the acquisitions of 3D, Check Please and Printprofil make ABT ready to move across national borders when the time is right, says Lindstrøm. Reference is made to the Cosmed buyout announcement made by the Company on 23 April 2024. Please see the attached form in accordance with article 19 of the EU Market Abuse Regulation. For further information, please contact CEO Håvard Lindstrøm mobile phone +47 941 32 288. Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skincare products. ABT’s cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skincare products developed by partners towards consumers and professional users. ABT’s focus on commercialization and development of natural ingredients and natural skincare products has been, and will continue to be, an important part of the Company’s strategy going forward. Aqua Bio Technology is listed on the Euronext Expand market of the Oslo Stock Exchange. This information is considered to be inside information pursuant to the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. This stock exchange notice was published by CEO Håvard Lindstrøm on the date and time provided. DISCLOSURE REGULATION This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act. CONTACTS Håvard Lindstrøm, 004794132288, hl@aquabiotech.no
    för 13 tim sedan · Ändrad
    för 13 tim sedan · Ändrad
    Vi er langt fra ferdige med Norge, men oppkjøpene av 3D, Check Please og Printprofil gjør ABT klar til å flytte over landegrensene når tiden er inne rett, sier Lindstrøm. Det vises til Cosmeds oppkjøpskunngjøring fra selskapet 23 april 2024.
Kommentarerna ovan kommer från användare på Nordnets sociala nätverk Shareville och har varken redigerats eller på förhand granskats av Nordnet. Det innebär inte att Nordnet tillhandahåller investeringsrådgivning eller investeringsrekommendationer. Nordnet påtar sig inget ansvar för kommentarerna eller eventuella felaktigheter i automatiska översättningar.
Q4-rapport
SNART
Idag
0,00 NOK/aktie
Senaste utdelning

Nyheter & Analyser

Nyheter och/eller generella investeringsrekommendationer alternativt utdrag därav på denna sida och relaterade länkar är framtagna och tillhandahålls av den leverantör som anges. Nordnet har inte medverkat till framtagandet, granskar inte och har inte gjort några ändringar i materialet. Läs mer om investeringsrekommendationer.
0,00 NOK/aktie
Senaste utdelning

Shareville

Delta i diskussionerna på SharevilleFå inspiration från tusentals portföljer och diskutera med andra duktiga investerare.
Logga in
  • för 7 tim sedan
    för 7 tim sedan
    De guider en kvart mrd på årsbasis og da blir det mer. Jesper Brant og Håvard Lindstrøm bør genierklæres. 15 kr pr aksje er antagelig svært billig. Jeg venter på neste oppkjøp👍😊🇳🇴
    för 7 tim sedan
    för 7 tim sedan
    Snart 250M i omsetning, sammenligner vi med f.eks Navamedic som i fjor hadde litt over 500M i omsetning og har nå en kurs på 34 kr. Så da er 16 kr et fint tall.
  • för 8 tim sedan
    för 8 tim sedan
    Da fikk vi Q1 allerede: av første kvartal 2024, oppnådde 35 millioner kroner i brutto omsetning på konsolidert basis med positiv EBITDA. https://kommunikasjon.ntb.no/ir-files/17847556/3067/4387/Download%20announcement%20as%20PDF.pdf
    för 7 tim sedan
    för 7 tim sedan
    Hold fast… 🍾
  • för 13 tim sedan
    för 13 tim sedan
    Er dette siden deres? https://www.3din.no/
  • för 13 tim sedan
    för 13 tim sedan
    Ha.ha. Dette var grisebra. Kjøpe omsetning til lav pris, hvor target har bunnlinje og god historikk. Dette er et distribusjonscase. Tenkt det hele tiden. Kursmål 15-20 på dagens setup. Jeg venter egentlig på neste oppkjøp…👏
    för 11 tim sedan
    för 11 tim sedan
    Mistet kalkulatoren? Er selskapet plutselig verdt et par milliarder?
  • för 14 tim sedan · Ändrad
    för 14 tim sedan · Ändrad
    Aqua Bio Technology (“ABT” or the “Company” and together with its wholly owned subsidiaries, the “ABT Group”) has today, on 25 April 2024, entered into an agreement (the “Agreement”) with CoC Invest AS (“CoC Invest”) regarding the Company’s acquisition of all of the outstanding shares in the 3D Innovation Nordic AS (“3D”). Pursuant to the Agreement, the Company shall further acquire all of the outstanding shares in the companies Printprofil AS and Check Please AS (jointly with 3D, the “Target Group”) from CoC Invest in connection with the acquisition of 3D (jointly, the “Acquisitions”). The Target Group represents a major wholesale group in the Nordics. In 2023, the Target Group had an unaudited turnover of NOK 87.6 million, of which 3D had a turnover of NOK 73 million. The Target Group companies are profitable and EBIDTA for the Target Group in 2023 ended jointly at NOK 5 million. The completion of the Acquisitions is subject to satisfactory due diligence and approval from ABT’s board of directors. Under the Agreement, the purchase price for the Acquisitions shall be settled in a combination of shares and cash, subject to certain conditions. NOK 5 million shares in ABT will be issued at a price of NOK 6 per share, with a 3-year lock up. The cash will be total NOK 15 million, divided into two installments, depending on the Target Group’s financial results. The first NOK 5 million is triggered by an EBT of NOK 6 million in the Target Group, the next NOK 10 million when the Target Group achieves an EBT of NOK 10 million. 3D is a significant wholesale company with a market-leading sales department. The company, which has its head office and sales department in Hønefoss, has extensive distribution to all the major retail chains in Norway and pharmacies in Norway and Sweden, as well as selected customers in Denmark. The company has had considerable success in just a few years and is at the top of the Gazelle award (Gaselle-bedrift) for 2023. In particular, the acquisition of 3D gives ABT access to completely new distribution channels that we do not currently have access to in both Norway and Sweden. In interaction with ABT’s historical operations and the operations in our existing subsidiaries, this acquisition will provide significant synergies on several levels, says Håvard Lindstrøm, CEO of ABT. Briefly about the companies Check Please AS mainly sells cash register rolls and rolls for card terminals in retail chains. The company’s founders have imported and sold cash register rolls/rolls for bank terminals from 2002, since 2014 as Check Please. The company has industry-leading expertise in this area. The company had an unaudited turnover of NOK 7.6 million in 2023. Printprofil AS is a company specialized in profiling and gift items, which is connected to New Wave and its thousands of customers. The company had an unaudited turnover of NOK 7 million in 2023. Scaling In addition to significant synergies between ABT’s historical and current operations, the acquisition of 3D also ensures that ABT gets the opportunity to scale its operations out of Norway to a greater extent. As of today, ABT’s presence outside Norway is limited in Sweden, through the ownership of Ultrabody AB. We are far from done with Norway, but the acquisitions of 3D, Check Please and Printprofil make ABT ready to move across national borders when the time is right, says Lindstrøm. Reference is made to the Cosmed buyout announcement made by the Company on 23 April 2024. Please see the attached form in accordance with article 19 of the EU Market Abuse Regulation. For further information, please contact CEO Håvard Lindstrøm mobile phone +47 941 32 288. Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skincare products. ABT’s cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skincare products developed by partners towards consumers and professional users. ABT’s focus on commercialization and development of natural ingredients and natural skincare products has been, and will continue to be, an important part of the Company’s strategy going forward. Aqua Bio Technology is listed on the Euronext Expand market of the Oslo Stock Exchange. This information is considered to be inside information pursuant to the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. This stock exchange notice was published by CEO Håvard Lindstrøm on the date and time provided. DISCLOSURE REGULATION This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act. CONTACTS Håvard Lindstrøm, 004794132288, hl@aquabiotech.no
    för 13 tim sedan · Ändrad
    för 13 tim sedan · Ändrad
    Vi er langt fra ferdige med Norge, men oppkjøpene av 3D, Check Please og Printprofil gjør ABT klar til å flytte over landegrensene når tiden er inne rett, sier Lindstrøm. Det vises til Cosmeds oppkjøpskunngjøring fra selskapet 23 april 2024.
Kommentarerna ovan kommer från användare på Nordnets sociala nätverk Shareville och har varken redigerats eller på förhand granskats av Nordnet. Det innebär inte att Nordnet tillhandahåller investeringsrådgivning eller investeringsrekommendationer. Nordnet påtar sig inget ansvar för kommentarerna eller eventuella felaktigheter i automatiska översättningar.

Orderdjup

Stängd
Antal
Köp
100
Sälj
Antal
1 000

Senaste avslut

TidPrisAntalKöpareSäljare
3 999--
1--
999--
1 200--
1 307--
Omsättning (NOK)
816 271

Vi vill bara påminna om att börsen ger och tar. Även om sparande i aktier historiskt gett god avkastning över tid finns inga garantier för framtida avkastning. Det finns risk att du inte får tillbaka de pengar du investerat.

Mäklarstatistik

Ingen data hittades

Kunder har även besökt

Företagshändelser

Nästa händelse
2023 Q4-rapport
26 apr.
Idag
Tidigare händelser
2023 Q2-rapport24 aug. 2023
2022 Årsstämma9 juni 2023
2022 Q4-rapport28 apr. 2023
2022 Q2-rapport24 aug. 2022
2021 Årsstämma9 juni 2022
Data hämtas från Millistream, Quartr

Relaterade värdepapper

Inga Nordnet Markets Certifikat finns med underliggande värdepapper. Se övriga Certifikat
© 2024 Nordnet Bank AB.
Nordnet | Box 30099 | 104 25 Stockholm